Japan's Government provides more than 501,000 dozes of AstraZeneca's COVID-19 vaccine to Tajikistan
Date
2/22/2022 1:03:48 AM
(MENAFN- Trend News Agency)
Ambassador Extraordinary and Plenipotentiary of Japan to
Tajikistan, Mr. Toshihiro Aiki, attended the ceremony for arrival
of 501,200 dozes of AstraZeneca vaccine provided by the Government
of Japan to Tajikistan through the COVAX mechanism, Trend reports with reference
to Asia-Plus .
The Embassy of Japan in Dushanbe says the ceremony took place at
the Republican Center of Immunoprophylaxis of Tajikistan in the
attendance of Mr. Abdukholiq Amirzoda, Deputy Minister of Health
and Social Protection of the Population of Tajikistan and Ms.
Zainab Al-Azzawi, Deputy Representative of UNICEF in
Tajikistan.
Tajikistan reportedly became the first country in Central Asia
to receive COVID-19 vaccine from the Government of Japan.
During the ceremony, Mr. Aiki indicated that health sector is
one of their priority areas in Japan-Tajikistan bilateral
cooperation, stating that he hopes 501,200 doses of Astra Zeneca
provided through the COVAX facility will contribute to save the
lives of Tajik people. Also he noted that Japan is committed to
work closely with the Government of Tajikistan to improve the
situation with pandemic.
In general, the Government of Japan has provided approximately
US$8 million worth of humanitarian aid to Tajikistan to combat the
pandemic.
The Government of Japan is dedicated to continuing its support
for creating a better society for all people and committed to
working together with the people of Tajikistan, the Embassy of
Japan in Dushanbe notes.
MENAFN22022022000187011040ID1103739480
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.